Patent · US Active

Plasma-supplemented formulation

US10806755B2 · kind B2 · utility

0Cited by

15References

5Claims

0Family size

Assignee

Omrix Biopharmaceuticals Ltd. · IL

Inventors

Roberto Meidler · Holon, IL
Elena Grimberg · Rehovot, IL
Oleg Belyaev · Petah Tikva, IL
Yonit Tiberman · Nes Ziona, IL
Israel Nur · Afula, IL
Tamar Auerbach-Nevo · Rehovot, IL

Key dates

Filing date	Feb 25, 2015
Grant date	Oct 20, 2020
Priority date	—
Expiry date	Feb 25, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y304/21005
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is a plasma-supplemented fibrinogen and/or fibrin formulation, method for the preparation and use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.